Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - Intra-Cellular Therapies, Inc. | d860502dex992.htm |
| EX-5.1 - EX-5.1 - Intra-Cellular Therapies, Inc. | d860502dex51.htm |
| EX-1.1 - EX-1.1 - Intra-Cellular Therapies, Inc. | d860502dex11.htm |
| 8-K - 8-K - Intra-Cellular Therapies, Inc. | d860502d8k.htm |
Exhibit 99.1
The registrant is filing this Exhibit 99.1 for the purpose of incorporating the information set forth herein by reference into the registration statement on Form S-3 (File No. 333-235817) that was filed by the registrant with the Securities and Exchange Commission on January 6, 2020 and became effective upon filing.
The following table sets forth the estimated costs and expenses, other than underwriting discounts and commissions, payable by the registrant in connection with the sale of the securities being registered:
| SEC Registration Fee |
$ | 44,035 | ||
| Printing and Engraving Expenses |
$ | 20,000 | ||
| Legal Fees and Expenses |
$ | 160,000 | ||
| Accounting Fees and Expenses |
$ | 150,000 | ||
| Transfer Agent and Registrar Fees |
$ | 5,000 | ||
| Miscellaneous |
$ | 20,965 | ||
|
|
|
|||
| Total |
$ | 400,000 |